Insider Transactions in Q4 2024 at Adc Therapeutics Sa (ADCT)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2024
|
Redmile Group, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+0.38%
|
$300,000
$3.05 P/Share
|
|
Dec 11
2024
|
Redmile Group, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.32%
|
$300,000
$3.05 P/Share
|
|
Dec 06
2024
|
Mohamed Zaki Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,112
-13.75%
|
$111,336
$3.13 P/Share
|
|
Dec 06
2024
|
Peter J Graham Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
41,458
-18.03%
|
$124,374
$3.13 P/Share
|
|
Dec 06
2024
|
Jose Carmona Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
48,108
-13.75%
|
$144,324
$3.13 P/Share
|
|
Dec 06
2024
|
Lisa Michelle Kallebo Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,503
-15.3%
|
$19,509
$3.13 P/Share
|
|
Dec 06
2024
|
Ameet Mallik Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
238,343
-20.42%
|
$715,029
$3.13 P/Share
|
|
Dec 04
2024
|
Redmile Group, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
50,672
+0.39%
|
$101,344
$2.07 P/Share
|
|
Dec 04
2024
|
Redmile Group, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
50,672
+0.32%
|
$101,344
$2.07 P/Share
|
|
Dec 04
2024
|
Redmile Group, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
50,672
-0.33%
|
$101,344
$2.07 P/Share
|
|
Dec 04
2024
|
Redmile Group, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
25,352
-0.16%
|
$50,704
$2.07 P/Share
|